Judge delivers blow to maker of Alzheimer's drug

The maker of the Alzheimer's drug Namenda announced it would stop selling the drug and was moving patients to a newer version called

Namenda XR. But New York's attorney general filed a lawsuit, saying the practice blocked competition and was illegal. Dr. Jon LaPook has the latest developments.